First-in-Human Trial Shows Synthetic Immune Cell Activator IMM60 Is Safe in Advanced Cancer
A first-in-human phase I trial found that the liposomal iNKT cell agonist IMM60, given alone or with pembrolizumab, was well ...
Tag: phase I trial
Experimental Drug Tolinapant Boosts Immunotherapy Response in Advanced Solid Tumors
A phase I trial found that the IAP antagonist tolinapant combined with pembrolizumab was well tolerated and produced a 33 ...
Engineered vaccinia virus GC001 shows potent tumour killing and clean safety profile
A thymidine kinase-deleted oncolytic vaccinia virus engineered to silence STRIP1 shows broad anti-tumour activity, ROS-Hippo pathway synergy and a clean ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!